Evidence mapPaperPMID 42601505Full record

ArticleEMBO reports2026

Polyunsaturated fatty acid sequestration protects against mitochondrial dysfunction-induced ferroptosis.

Guillermo Puertas-Frías, María José Saucedo-Rodríguez, Kristýna Čunátová, Lukáš Alán, Patrik Hrbáč, Michal Knězů, Soňa Koníčková, Jakub Schimmer, Monika Krakovková, Marek Vrbacký and 10 more

Abstract read
PubMed Publisher
In one paragraph

Article in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Guillermo Puertas-Frías *Laboratory of Bioenergetics, Institute of Physiology, Czech Academy of Sciences, Vídeňská 1083, Prague, Czech Republic.ORCID http://orcid.org/0000-0003-0580-3833
María José Saucedo-Rodríguez *Laboratory of Bioenergetics, Institute of Physiology, Czech Academy of Sciences, Vídeňská 1083, Prague, Czech Republic.ORCID http://orcid.org/0009-0003-4646-1312
Kristýna ČunátováLaboratory of Bioenergetics, Institute of Physiology, Czech Academy of Sciences, Vídeňská 1083, Prague, Czech Republic.
Lukáš AlánLaboratory of Bioenergetics, Institute of Physiology, Czech Academy of Sciences, Vídeňská 1083, Prague, Czech Republic.
Patrik HrbáčLaboratory of Bioenergetics, Institute of Physiology, Czech Academy of Sciences, Vídeňská 1083, Prague, Czech Republic.
Michal KnězůLaboratory of Bioenergetics, Institute of Physiology, Czech Academy of Sciences, Vídeňská 1083, Prague, Czech Republic.ORCID http://orcid.org/0009-0007-6098-4426
Soňa KoníčkováLaboratory of Bioenergetics, Institute of Physiology, Czech Academy of Sciences, Vídeňská 1083, Prague, Czech Republic.
Jakub SchimmerLaboratory of Metabolism of Bioactive Lipids, Institute of Physiology, Czech Academy of Sciences, Vídeňská 1083, Prague, Czech Republic.
Monika KrakovkováLaboratory of Metabolism of Bioactive Lipids, Institute of Physiology, Czech Academy of Sciences, Vídeňská 1083, Prague, Czech Republic.ORCID http://orcid.org/0009-0007-5556-3408
Marek VrbackýLaboratory of Bioenergetics, Institute of Physiology, Czech Academy of Sciences, Vídeňská 1083, Prague, Czech Republic.
Tomáš ČajkaLaboratory of Metabolomics, Institute of Physiology, Czech Academy of Sciences, Vídeňská 1083, Prague, Czech Republic.ORCID http://orcid.org/0000-0002-9728-3355
Ondřej KudaLaboratory of Metabolism of Bioactive Lipids, Institute of Physiology, Czech Academy of Sciences, Vídeňská 1083, Prague, Czech Republic.ORCID http://orcid.org/0000-0001-7034-4536
Erika Fernández-VizarraDepartment of Biochemistry and Molecular and Cellular Biology. Faculty of Health and Sport Sciences. University of Zaragoza, Zaragoza, Spain.
Massimo ZevianiIRCCS Women and Children's Hospital "Burlo-Garofolo", Trieste, Italy.
Hana HansíkováDepartment of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University, General University Hospital, Prague, Czech Republic.
Tomáš HonzíkDepartment of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University, General University Hospital, Prague, Czech Republic.
Josef HouštěkLaboratory of Bioenergetics, Institute of Physiology, Czech Academy of Sciences, Vídeňská 1083, Prague, Czech Republic.ORCID http://orcid.org/0000-0002-8413-4772
Petr PecinaLaboratory of Bioenergetics, Institute of Physiology, Czech Academy of Sciences, Vídeňská 1083, Prague, Czech Republic.ORCID http://orcid.org/0000-0003-0641-2834
Tomáš MráčekLaboratory of Bioenergetics, Institute of Physiology, Czech Academy of Sciences, Vídeňská 1083, Prague, Czech Republic.ORCID http://orcid.org/0000-0002-9492-0718
Alena PecinováLaboratory of Bioenergetics, Institute of Physiology, Czech Academy of Sciences, Vídeňská 1083, Prague, Czech Republic. alena.pecinova@fgu.cas.cz.ORCID http://orcid.org/0000-0002-0204-7502

Funding

Akademie Věd České Republiky (CAS) 67985823Akademie Věd České Republiky (CAS) 68378050EC | European Regional Development Fund (ERDF) CZ.02.1.01/0.0/0.0/18_046/0016045Grantová Agentura České Republiky (GAČR) 21-18993SGrantová Agentura, Univerzita Karlova (GA UK) 283423/2023Ministerstvo Školství, Mládeže a Tělovýchovy (MEYS) LM2023050Ministerstvo Školství, Mládeže a Tělovýchovy (MEYS) LX22NPO5104Ministerstvo Zdravotnictví Ceské Republiky (MZCR) NU22-01-00499
6 · The paper itself

Abstract

Impaired energy production is a hallmark of mitochondrial oxidative phosphorylation (OXPHOS) defects. However, secondary metabolic disturbances also represent an important trigger for pathologies originating from OXPHOS aberrations. Here we show that cells with OXPHOS deficiencies accumulate triacylglycerols enriched in polyunsaturated fatty acids (PUFAs), which are stored in lipid droplets. Sequestration of PUFAs is a critical component of a broader stress response, which also includes downregulation of cellular desaturases and upregulation of glutathione peroxidase 4 (GPX4). We demonstrate that this mechanism represents a physiologically relevant protective strategy, manifesting in cells under hypoxia and in immortalised fibroblasts derived from patients with primary mitochondrial complex IV deficiency. As a proof of principle, we observe elevated PUFA-enriched triacylglycerols in the plasma of patients with Myoclonic Epilepsy with Ragged Red Fibres (MERRF). Our findings reveal a novel protective mechanism against ferroptosis, which preserves membrane integrity when mitochondrial respiration is compromised.

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.